News
(2) We leveraged this opportunity to combine these building blocks, generating multimeric siRNAs through strain-promoted azide–alkyne cycloaddition ... In this work, a system consisting of an siRNA ...
AbbVie has signed a collaboration and licensing agreement with US-based ADARx Pharmaceuticals, committing $335m upfront to access its small interfering RNA (siRNA) platform. The partnership gives ...
AbbVie is paying ADARx Pharmaceuticals $335 million upfront to secure options on next-gen small interfering RNA (siRNA) therapeutics across several disease areas. The collaboration and license ...
CRISPR Therapeutics CRSP announced that it has entered into a collaboration deal with San Diego-based privately held company, Sirius Therapeutics, for developing and commercializing novel siRNA ...
Late clinical-stage biotech ADARx is working on small interfering RNA, or siRNA, therapeutics, a class of molecules capable of regulating gene expression and protein production. The strategic ...
Crispr will also be able to nominate up to two siRNA targets for research and development, for which it would retain opt-in rights to lead commercialization, the companies said. Sirius will be ...
The Vallabh/Minikel lab has received FDA clearance for the compound, a divalent short interfering RNA (siRNA) intended for delivery via intrathecal injection, as an Investigational New Drug for ...
TAIPEI, May 19, 2025 /PRNewswire/ -- Linker Vision, a leading AI software company from Taiwan, unveils its latest advancements in large-scale urban AI deployments at COMPUTEX 2025. The showcase ...
Labour Against Antisemitism has called on the BBC to remove Gary Lineker from all football coverage over an Instagram post of an 'antisemitic' rat emoji. The campaign group has lodged a formal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results